Efficacy and safety of a new mechanical balloon-based flow diverter in the treatment of intracranial aneurysms

医学 闭塞 分流器 气球 不利影响 狭窄 外科 前瞻性队列研究 动脉瘤 放射科 内科学
作者
Jingwei Li,Wei Ni,Yuanyuan Lu,Li Li,Chuan He,Chao Gao,Tianxiao Li,Xinjian Yang,H. Zhang
出处
期刊:Journal of NeuroInterventional Surgery [BMJ]
卷期号:: jnis-023225
标识
DOI:10.1136/jnis-2025-023225
摘要

Background Flow diverters (FDs) are the first-line treatment of intracranial aneurysms (IAs). A groundbreaking mechanical balloon-based FD device was developed to enhance the precise landing and deployment efficiency for FDs. Objective To investigates the efficacy and safety of this innovative device in a prospective cohort. Methods This study was a prospective multicenter observational study conducted between September 2019 and November 2021. Patients diagnosed with unruptured IAs and treated with this innovative FD device alone were included. The immediate implantation success rate, the successful aneurysm occlusion rate (Raymond I–II or OKM C–D), the complete occlusion rate (Raymond I or OKM D), and the parent artery stenosis rate (>50%) at follow-up were evaluated as the evaluation index of efficacy. The mortality rate, adverse events (AEs), neurological AEs, and serious adverse events (SAEs) were evaluated as the evaluation index of safety. Results A total of 128 patients were included, and all of the FD deployments were successful (success rate reached 100%). At the 12-month mark, 91.4% (117/128) of patients achieved successful occlusion, 85.9% (110/128) achieved complete occlusion, and only 0.8% (1/128) exhibited parent artery stenosis >50% (without need for additional treatment). During the follow-up, there were no reported mortalities or cerebral hemorrhage, while 6 neurological adverse events (4.69%) and 4 SAEs (3.1%) were observed. Conclusions The mechanical balloon-based FD showed a remarkable occlusion rate alongside minimal ischemic and hemorrhagic adverse events compared with existing FDs. This innovative mechanical balloon-based design may be an important direction for future FD design.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
李寳完成签到,获得积分10
刚刚
xxw完成签到,获得积分10
刚刚
电解质完成签到,获得积分10
刚刚
千流完成签到,获得积分10
刚刚
研友_Ljqal8发布了新的文献求助10
1秒前
help完成签到,获得积分10
1秒前
hus完成签到,获得积分10
1秒前
tyro完成签到,获得积分10
1秒前
蓬莱依月完成签到,获得积分10
1秒前
husky完成签到,获得积分10
2秒前
马俊完成签到,获得积分10
2秒前
HZN完成签到,获得积分10
2秒前
3秒前
Harrisonhuang完成签到,获得积分10
3秒前
GGbond完成签到,获得积分10
3秒前
啊哈完成签到,获得积分10
3秒前
超帅发夹完成签到 ,获得积分10
3秒前
白敬亭发布了新的文献求助10
4秒前
guan完成签到,获得积分10
4秒前
Ywwww完成签到 ,获得积分10
5秒前
小太阳完成签到,获得积分10
6秒前
6秒前
天真的完成签到,获得积分10
6秒前
jiaxiangyu完成签到,获得积分10
6秒前
夜瞳完成签到,获得积分10
6秒前
Polly完成签到,获得积分10
7秒前
马麻薯完成签到,获得积分10
7秒前
林慕然2023完成签到,获得积分10
7秒前
深井的朵拉完成签到,获得积分10
8秒前
研友_VZG7GZ的应助被杨媛采纳,获得10
8秒前
8秒前
33完成签到 ,获得积分10
8秒前
8秒前
luyue9406的应助被MINI采纳,获得20
9秒前
bulanshitake完成签到,获得积分10
9秒前
9秒前
姚波完成签到,获得积分10
9秒前
卡佳完成签到,获得积分10
9秒前
笔不尖完成签到 ,获得积分10
10秒前
鱼湘完成签到,获得积分10
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180146
求助须知:如何正确求助?哪些是违规求助? 9570319
关于积分的说明 21809739
捐赠科研通 7776294
什么是DOI,文献DOI怎么找? 3433266
关于科研通互助平台的介绍 2557483
邀请新用户注册赠送积分活动 2479039